Amvuttra® (vutrisiran)
| Full Name | Amvuttra® (vutrisiran) |
| Drug | Amvuttra |
| Manufacturer | Alnylam Pharmaceuticals, Inc. |
| Route of Administration | Subcutaneous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults |
| Disease | Hereditary ATTR amyloidosis (hATTR) – Polyneuropathy (PN) |
| Therapeutic Area | Neurology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-372-9581 |
| Fax Number | 877-349-7938 |
| Product Website | amvuttrahcp.com |